Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Fujifilm Biosciences Inc. currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. This prosecution activity is distributed across 2 distinct examiners and 2 distinct art units, indicating a diverse spread of examination for a portfolio of this size. The involvement of multiple art units suggests that the company's intellectual property covers different technical niches within the pharmaceutical sector.
TINSLEY, BRENDAN THOMAS is identified as the busiest examiner for the company, currently overseeing 1 pending office action. This single action represents 1 of the 2 pending office actions for the portfolio. The use of 2 distinct art units suggests that the company's intellectual property covers multiple specialized sub-sectors. Practitioners should note that with 2 distinct art units involved, the prosecution strategy must account for the specific guidelines and tendencies of different technical groups within the patent office to resolve the 2 pending office actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TINSLEY, BRENDAN THOMAS | 1 | 60.4% | +74.3% |
| CHANG, SUKWOO JAMES | 1 | 58.0% | +41.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18571618 | METHOD AND USE OF A TRANSGENIC MOUSE LINE | TINSLEY, BRENDAN THOMAS | — |
| 18529976 | SYSTEM AND METHOD FOR LIFTING AND ORIENTING A CHAMBER | CHANG, SUKWOO JAMES | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18571618 | METHOD AND USE OF A TRANSGENIC MOUSE LINE | TINSLEY, BRENDAN THOMAS | — |
| 18529976 | SYSTEM AND METHOD FOR LIFTING AND ORIENTING A CHAMBER | CHANG, SUKWOO JAMES | — |
| Art Unit | Apps |
|---|---|
| 1634 | 1 |
| 3723 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18571618 | METHOD AND USE OF A TRANSGENIC MOUSE LINE | TINSLEY, BRENDAN THOMAS | 1634 | §102§103§112 | Non-Final OA | — | Pending | Dec 18, 2023 |
| 18529976 | SYSTEM AND METHOD FOR LIFTING AND ORIENTING A CHAMBER | CHANG, SUKWOO JAMES | 3723 | §103§112 | Final Rejection | — | Pending | Dec 05, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFujifilm Biosciences Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Brendan Thomas Tinsley has the most, with 1 of Fujifilm Biosciences Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
